Recent developments in the treatment of adult atopic dermatitis Print E-mail

 

 

Australas J Dermatol. 2006 May;47(2):84-9.

 

Recent developments in the treatment of adult atopic dermatitis.

 

Pua VS, Barnetson RS.

 

Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

 

Atopic dermatitis is a common inflammatory skin condition with increasing incidence in recent decades. The mainstay of treatment has been the combination of emollients and topical corticosteroids, with the addition of systemic therapies in severe cases. New drugs such as the topical calcineurin inhibitors have shown promise in treating mild-to-severe atopic dermatitis. Other novel therapies that have been reported in the literature include leukotriene antagonists, monoclonal antibodies such as infliximab, leflunomide, recombinant interferon gamma and intravenous immunoglobulin. This review will focus on the treatment of adult atopic dermatitis.

 

Publication Types:
Review

 

PMID: 16637800 [PubMed - indexed for MEDLINE]


Full Article Available Online

 

 

 

{mosgoogle}

 

{mos_sb_discuss:13}

 


 

Comments (0)Add Comment

Write comment

busy
 

 

Latest Comments

EiR on Facebook

Follow us on Facebook

EiR on Google+



EiR on Twitter


Follow The EiR on Twitter

Online Members

0 users online